You are here:--Drug Discovery Data Insights: Highly Accessible SAR Data is Transforming the Drug Discovery Informatics Landscape

Drug Discovery Data Insights: Highly Accessible SAR Data is Transforming the Drug Discovery Informatics Landscape

On June 26th, 2018, Collaborative Drug Discovery (CDD) hosted a webinar where moderator Ashley Farley, Associate Officer of Knowledge & Research Services at the Bill & Melinda Gates Foundation (BMGF) discussed drug discovery data with Dr. Andrew Leach from ChEMBL and Dr. Evan Bolton from PubChem.

The presenters discussed the emergence of freely available PubChem and ChEMBL resources for chemical and biological Structure-Activity-Relationship (SAR) data and their impact on the global drug discovery informatics landscape.

The relationship between chemical structure and biological activity is commonly referred as Structure Activity Relationship (SAR). SAR assessments are generated via computational tools, data correlations, and models. SAR is useful for assessment of drug properties and risks from early discovery to candidate selection, and as for other drug classes it has been successfully used in antibacterial discovery.

To watch the recording, please visit the CDD website.

2019-01-11T15:25:30+00:00